Skip to main content
. 2015 Jan 13;19(3):608–619. doi: 10.1111/jcmm.12445

Fig 6.

Fig 6

Schematic diagram of the mechanism whereby miR-16 attenuation contributes to myocardial hypertrophy. Activation of the STAT3/c-Myc signalling pathway negatively regulates miR-16 expression during cardiac hypertrophy. In addition, attenuation of miR-16 derepresses the cyclins D1, D2 and E1 and activates cyclin/Rb pathway to provoke cardiomyocyte hypertrophy.